Loading…

Tacrolimus causes reduced GLI1 expression and phenotypic changes in the TE 354.T basal cell carcinoma cell line

Saved in:

Bibliographic Details
Published in:	Journal of dermatological science 2009-04, Vol.54 (1), p.52-54
Main Authors:	Di Gennaro, P, Sestini, R, Bacci, S, Pacini, A, Pinzani, P, Domenici, L, Toscano, A, Massi, D, Carli, P, Genuardi, M, Romagnoli, P
Format:	Article
Language:	English
Subjects:	BCL-2 Blood Coagulation Factors - drug effects Blood Coagulation Factors - metabolism Carcinoma, Basal Cell - metabolism Carcinoma, Basal Cell - pathology Cell Line, Tumor Dermatology Electron microscopy Gene Expression - drug effects GLI1 Humans Immunocytochemistry Immunosuppressive Agents - pharmacology Laminin Patched Receptors Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors Proto-Oncogene Proteins c-bcl-2 - metabolism Receptors, Cell Surface - drug effects Receptors, Cell Surface - metabolism Receptors, G-Protein-Coupled - drug effects Receptors, G-Protein-Coupled - metabolism Smoothened Receptor Tacrolimus - pharmacology TE 354.T Transcription Factors - antagonists & inhibitors Transcription Factors - metabolism Zinc Finger Protein GLI1
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!